{
    "authors": [
        {
            "affiliations": [],
            "name": "Asma Pedi\u00e1trica"
        },
        {
            "affiliations": [],
            "name": "Juan Trujilloa"
        },
        {
            "affiliations": [],
            "name": "Caoimhe Croninb"
        }
    ],
    "id": "SP:9f39bb91efaa6e2486be7068d43c41d0ead22dfa",
    "references": [
        {
            "authors": [
                "J Brown",
                "D Tuthill",
                "M Alfaham",
                "E. Spear"
            ],
            "title": "A randomized maternal evaluation of epinephrine autoinjection devices. Pediatr Allergy Immunol",
            "year": 2048
        },
        {
            "authors": [
                "MS Gold",
                "R. Sainsbury"
            ],
            "title": "First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (Epipen\u00ae)",
            "venue": "J Allergy Clin Immunol. 2000;106(1",
            "year": 2000
        },
        {
            "authors": [
                "Arkwright PD",
                "Farragher AJ"
            ],
            "title": "Factors determining the ability of parents to effectively administer intramuscular adrenaline to food allergic children",
            "venue": "Pediatr Allergy Immunol",
            "year": 2006
        },
        {
            "authors": [
                "CJ Jones",
                "CD Llewellyn",
                "AJ Frew",
                "G du Toit",
                "S Mukhopadhyay",
                "H. Smith"
            ],
            "title": "Factors associated with good adherence to self-care behaviours amongst adolescents with food allergy",
            "venue": "Pediatr Allergy Immunol",
            "year": 2015
        },
        {
            "authors": [
                "S Kapoor",
                "G Roberts",
                "Y Bynoe",
                "M Gaughan",
                "P Habibi",
                "G. Lack"
            ],
            "title": "Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions",
            "venue": "Allergy. 2004;59:185\u201391",
            "year": 2003
        },
        {
            "authors": [
                "T Umasunthar",
                "A Procktor",
                "M Hodes",
                "JG Smith",
                "C Gore",
                "HE Cox"
            ],
            "title": "Patients\u2019 ability to treat anaphylaxis using adrenaline autoinjectors: A randomized controlled trial. Allergy",
            "year": 2015
        },
        {
            "authors": [
                "MN Robinson",
                "SC Dharmage",
                "MLK. Tang"
            ],
            "title": "Comparison of adrenaline auto-injector devices: Ease of use and ability to recall use",
            "venue": "Pediatr Allergy Immunol",
            "year": 2014
        },
        {
            "authors": [
                "SH Sicherer",
                "JA Forman",
                "SA. Noone"
            ],
            "title": "Use assessment of selfadministered epinephrine among food-allergic children and pediatricians [Internet",
            "venue": "Available from: www.aappublications. org/news",
            "year": 2000
        },
        {
            "authors": [
                "SH Sicherer",
                "PA Vargas",
                "ME Groetch",
                "L Christie",
                "SK Carlisle",
                "S Noone"
            ],
            "title": "Development and validation of educational materials for food allergy",
            "venue": "J Pediatr",
            "year": 2012
        },
        {
            "authors": [
                "N Segal",
                "B Garty",
                "V Hoffer",
                "Y. Levy"
            ],
            "title": "Effect of instruction on the ability to use a self-administered epinephrine injector",
            "year": 2012
        }
    ],
    "sections": [
        {
            "text": "*Corresponding author: Juan Trujillo, Department of Paediatrics and Child Health, University College Cork, Cork University Hospital, Ireland. Email address: juan.trujillo@ucc.ie\nhttps://doi.org/10.15586/aei.v50i5.582 Copyright: Trujillo J and Cronin C License: This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/\nKEYWORDS Caregivers; parents; adrenaline; auto-injector; adrenaline\nfood-allergy; anaphylaxis\ncarried out to identify literature with relevance to the research topic to achieve the above stated objectives.\nThe filters that were applied to both PubMed and Wiley Online Library search results are shown in Table 1."
        },
        {
            "heading": "Inclusion and exclusion criteria",
            "text": "Due to the niche topic of this literature review, articles dating back to 2000 were used, many of which proved to be relevant and had they not been accounted for, would have resulted in a much narrower review of the chosen topic.\nSeveral inclusion and exclusion criteria were applied to the search results obtained in both databases, which are outlined in Table 2."
        },
        {
            "heading": "Selection criteria",
            "text": "The initial PubMed search produced 14 results and Wiley Online Library search yielded 631 results, which were then condensed down to 13 and 323 results, respectively, after filter application. Of these 336 studies, 286 failed to satisfy the inclusion criteria. The remaining 50 studies were analysed in full to further refine the selection (Figure 1). A total of 10 articles were ultimately selected for the literature review.\nThe reasons for excluding articles during the screening and eligibility stages are outlined in Tables 3 and 4."
        },
        {
            "heading": "Validity of articles",
            "text": "All articles analysed in this literature review were critically evaluated using the EBL Critical Appraisal Checklist (Appendix A)."
        },
        {
            "heading": "Results",
            "text": "Of the 10 studies selected for review, 5 were conducted in the UK,2,4\u20137 2 were conducted in Australia,3,8 another 2 conducted in the USA9,10 and 1 was conducted in Israel.11 There was a range of sample sizes among the studies (60\u2013188), with a mean of 115.5. The articles were analysed in the categories of population, study methodology, AAI assessment tool used, key findings and strengths and limitations. A summary of the 10 articles is shown in Table 5.\nThe average validity score using the EBL Critical Appraisal Checklist was 82.5%, with the validity scores in each section summarised in Table 6."
        },
        {
            "heading": "Introduction",
            "text": "Children diagnosed with a food allergy require longterm follow up with paediatric allergy specialists, nurses and dieticians to understand the prevention and correct manage ment in the case of accidental exposure which can produce a broad spectrum of allergic reactions.\nAnaphylaxis is a severe allergic reaction associated with lower respiratory or cardiovascular features1 that can be rapid in onset and occasionally fatal.2 Although anaphylaxis is uncommon, the incidence is increasing, with the highest number of cases being seen in children and adolescents.2 Mortality from anaphylaxis is uncommon yet well documented and is usually the result of hypoxia resulting from cardiovascular collapse, airway tract obstruction or pulmonary oedema.3\nAdrenaline is the drug of choice for the treatment of anaphylaxis.3 It is therefore recommended that children at risk of food-induced anaphylaxis have access to their prescribed adrenaline autoinjector, be it at home, school or out and about.4 Parents and children who have been prescribed an adrenaline autoinjector (AAI) should be given instruction and guidance on when and how to use it by a trained healthcare professional.2 However, many patients and caregivers are often unable to demonstrate correct administration of the devices when assessed.2 This may reflect several issues including training effectiveness or lack of training, user stress during administration or inherent differences consequent of the design of the individual autoinjector.2"
        },
        {
            "heading": "Aim",
            "text": "The aim of this literature review is to search for and appraise the existing literature related to administration techniques of adrenaline autoinjectors for caregivers and patients with food allergies."
        },
        {
            "heading": "Objectives",
            "text": "The objectives of this review are to: 1. Quantitively evaluate the administration techniques of\nadrenaline autoinjectors in caregivers and children diagnosed with food allergy. 2. Describe the effects of educational or training interventions on the administration technique of adrenaline autoinjectors in parents and children diagnosed with a food allergy. 3. Explore the factors which may influence the administration technique of adrenaline autoinjectors in caregivers and children with food allergies."
        },
        {
            "heading": "Methods",
            "text": ""
        },
        {
            "heading": "Search strategy",
            "text": "Two databases were utilised, namely PubMed and Wiley Online Library, to carry out an electronic search. This was\nTable 1 List of filters that were applied to PubMed and Wiley Online Library.\nNumber Filter Specification\n1 Publication date 2000\u20132021 2 Language English 3 Publication type Journal"
        },
        {
            "heading": "The effect of a training or educational",
            "text": "intervention on adrenaline autoinjector administration technique\nFive studies compared the AAI administration technique of participants both before and after receiving an educational or training intervention.6\u20138,10,11 A clinical nurse specialist educated the participating families on the usage of an Epipen\u00ae.6 At baseline, 13 (50%) of those who were prescribed an Epipen\u00ae could identify all three critical steps, which improved to 22 (97.5%) after receiving the educational intervention, with an improvement of 83%.6\nWhen participants were trained by an allergist in either Epipen\u00ae or Anapen\u00ae, 84% correctly demonstrated the use of the AAI before training (79.25% Anapen\u00ae, 89.26% Epipen\u00ae), which improved to 100% in both cohorts after training.8 In a follow-up study 3 months later, the ability to recall Anapen\u00ae was 37% compared to 87% for Epipen\u00ae.8\nWhen participants received written instructions and training from a physician on the use of Epipen\u00ae, the mean score of this subgroup improved from 4.71 \u00b1 3.04 to 6.7 \u00b1 3.18 (P < 0.001).11\nWhen developing and validating educational materials for parents of children with allergies, ability to perform all steps increased from 18 to 95% after training (mean scores increased from 3.4 to 5.95, P < 0.001).10 The mean score declined to 5.47 after 1 year, still significantly above baseline.10\nAdrenaline autoinjector administration technique among paediatric patients and caregivers\nAll 10 studies assessed the AAI administration ability.2,3\u201311 Seventy-eight percent of parents who had never been trained in the use of an AAI were unable to trigger it, while 35% of parents who had received a demonstration too failed to trigger it.4 Twelve percent of mothers performed all 10 steps successfully with Epipen\u00ae compared to 32% of mothers with Anapen\u00ae.2 Twenty-four percent of parents could recall all four steps of Epipen\u00ae in one study,3 compared to 50% who could identify all three critical steps of Epipen\u00ae in another study.6 Eighty-nine percent and 79% of parents successfully administered Epipen\u00ae and Anapen\u00ae, respectively, after 2 min of familiarising with them.8 Eighteen percent of parents performed all six steps of an unidentified AAI administration correctly.10\nIn studies where paediatric patients\u2019 ability to use an AAI was assessed, there was a mean score of 7.78/9 for AAI knowledge among adolescents, and 18% could identify all nine steps correctly.5\nTwo studies compared AAI administration among both parents and patients.9,11 In one study, 19% received a score of 0 when assessed in Epipen\u00ae use, while only eight (5.6%) scored the maximum 10 with a mean of 4.03 \u00b1 3.11 The other study reported that 32% of the participants demonstrated the use of the AAI correctly.9\nTa bl\ne 5\nSu m\nm ar\ny of\nr es\nul ts\no f\nch os\nen a\nrt ic\nle s.\nAu th\nor (\nYe ar ) Lo ca ti on Ti tl e\nO bj\nec ti\nve s\nPo pu\nla ti on sa m pl e si\nze St\nud y\nm et\nho do\nlo gy\nAs se\nss m\nen t\nto ol\nu se\nd Ke\ny fin\ndi ng\ns St\nre ng\nth s\nan d\nlim it\nat io\nns\nAr kw\nri gh\nt &\nFa\nrr ag\nhe r\n(2 00\n6) 4\nU K Fa ct\nor s\nde te\nrm in\nin g\nth e\nab ili\nty o\nf pa\nre nt s to e ff ec ti ve ly ad m in is te r in tr am us cu la r ad re na lin e to ch ild re n al le rg ic to f oo d\nTo d\net er\nm in e w hi ch f ac to rs ar e m os t st ro\nng ly\nas\nso ci\nat ed\nw it h th e eff ec ti ve u\nse\nof A\nAI .\nCo nv\nen ie\nnc e\nsa m\npl e\nof\nch ild\nre n\nw ho\nco\nns ec\nut iv\nel y\nat te\nnd ed\na\nsi ng\nle s\npe ci\nal is t pa ed ia tr ic al le rg y cl in ic in M an ch es te r U K, be tw ee n N ov 20 04 a nd A ug 20 05 , w ho w er e di ag no se d w it\nh a\nfo od\na lle\nrg y\nan d\npr es\ncr ib\ned a n A AI . Pa re nt s of 1\n22\nch ild\nre n\nPa re\nnt s\nw er\ne gi\nve n\nan E\npi pe\nn\u00ae t\nra in\ner\npe n\nan d\nas ke\nd to\nde\nm on\nst ra\nte it\ns us\ne.\nCa re\nrs w\ner e\nas se\nss ed\non\nt he\nir k\nno w\nle dg\ne of\nus\nin g\nA AI\nin d\niff er\nen t\nsi tu\nat io\nns ,\nsu ch\na s\nw he\nn a\nch ild\nh ad\nbr\nea th\nin g\ndi ffi\ncu lt\nie s\nor f\nai nt\nne ss . A su rv ey w as di st ri bu te d\nto c\nol le\nct\nin fo\nrm at\nio n\nre ga\nrd in g de m og ra ph ic s, a lle rg y di ag no si s, p re sc ri be r of A AI , pr ev io us A AI tr ai ni ng a nd p re vi ou s al le rg ic r ea ct io ns .\nCa re\ngi ve\nr de\nem ed\nun\nab le\nt o\nus e\nA AI\nif\nth ey\n(1 )\nha d\nno id\nea\nho w\nt o\nus e\nA AI\n( 2)\nd id\nno\nt kn\now t\nhe c\nor re\nct\nsi te\nt o\nin je\nct A\nAI\n(3 )\nfa ile\nd to\nr em\nov e\nsa fe\nty c\nap (\n4) f\nai le\nd to\nap\npl y\nen ou\ngh p\nre ss\nur e\nto t\nri gg\ner d\nev ic\ne or\n(5\n) to\nok t\nhe n\nee dl e ou t of t he s ki n im m ed ia te ly a ft er th e de vi ce h ad b ee n tr ig ge re d.\nPa re\nnt s\nof c\nhi ld\nre n\nse en\nb y\nan\nal le\nrg y\nsp ec\nia lis\nt w\ner e\nm or e lik el y to b e ab le t o tr ig ge\nr th e de vi ce t ha n pa re nt s w ho se ch ild re n ha d be en s ee n by a\nG P\nor n\non -a\nlle rg\ny sp\nec ia\nlis t.\n19\n% ha\nd ne\nve r\nbe en\ns ho\nw n\nho w\nt o\nus e\nth e\nde vi\nce ,\nan d\nof t\nhe se\n, 78\n% w\ner e\nun ab\nle t o tr ig ge r it , co m pa re d to 3 5% w\nho\nha d\nbe en\ng iv\nen a\nt le\nas t\non e\nde m\non st\nra ti\non .\nPa re\nnt s\nw ho\na tt\nen de\nd an\na lle\nrg y\nse lf-\nhe lp\ng ro\nup w\ner e\nm or e lik el y to b e ab le t o us e th\nei r\nA AI\n[ 4.\n4 (2\n.0 \u20139\n.6 )\nod ds\nr at\nio\n(9 5%\nC I].\nP ar\nen t\nof c\nhi ld\nre n\nw ho\nha\nd an\nH x\nof s\nev er\ne al\nle rg\nic\nre ac\nti on\nw er\ne no\nm or\ne lik\nel y\nto s\nuc ce\nss fu\nlly u\nse t\nhe A\nAI [\n4. 8\n(1 .6\n\u20131 3.\n7) v\ns 4.\n8 (1\n.6 \u20131\n3. 7)\no dd s ra ti o (9 5% C I)] .\nSt re\nng th : 1. L ar ge s\nam pl\ne si\nze o f ch ild re n FA . 2. P ar en ts a sk ed t o de m on st ra te E pi pe\nn\u00ae u\nse\nw it\nh tr\nai ne\nr pe n 3. E xt en si ve s tu dy\no f\npa re\nnt\nan d\npa ti\nen t\nch ar\nac te\nri st\nic s\nto d\net er\nm in\ne th\nei r\npo ss\nib le\nas\nso ci\nat io\nns w\nit h\nA AI\nu se . Li m it at io ns : 1. D at a re ga rd in g w ha t pa re\nnt s\nw ho\nc ou\nld n\not fi\nre t\nhe A\nAI\nfa ile\nd to\nd o\nno t\nde sc\nri be\nd.\n2. S\nug ge\nst io\nns f\nor f\nur th\ner\nre se\nar ch\nn ot\nd es\ncr ib\ned .\nBr ow\nn et\na l.\n(2\n01 3)\n2\nU K A ra\nnd om\nis ed\nm\nat er\nna l\nev al\nua ti\non o f ep in ep hr in e au to in je ct io n de vi ce s\nTo e\nva lu\nat e\n(1 )\nm at\ner na l co m pe te nc e in u si ng A AI fo llo w in g a st an da rd an ap hy la xi s tr ai ni ng p\nac ka\nge\nan d\n(2 )\nw hi\nch\nou t\nof t\nhe t\nw o\nde vi\nce s\nw as\nfo\nun d\nto b e ea si er t o\nus e\nby\nm ot\nhe rs\nM ot\nhe rs\no f\nch ild\nre n\nat te\nnd in\ng ge\nne ra l pa ed ia tr ic ou tp at ie nt de pa rt m en ts an d in pa ti en t ch ild re n\u2019 s w ar ds in o ne t er ti ar y ho sp it al w it h no p re vi ou s A AI kn ow le dg e or ex pe ri en ce . 10 0 m ot he rs\nM ot\nhe rs\nw er e ra nd om is ed\nt o\nre ce\niv e\ntr ai\nni ng\nin e\nit he r Ep ip en \u00ae ( n = 50 )\nor\nAn ap\nen \u00ae (\nn =\n50 ).\n30 -m\nin s\nta nd\nar di\nse d\nin di\nvi du\nal\nde m\non st\nra ti\non o n A AI u se f ol lo w ed by im m ed ia te ev al ua ti on .\nEv al\nua te\nd by\n1 0\npr e-\nde te\nr m in\ned c\nri te\nri a.\nS ix\nof\nt he\nse w\ner e\nco m\nm on\nto\nb ot\nh AA\nI. (1 ) Re as su re s an d\nex pl\nai ns\npr\noc ed\nur e\nto c\nhi ld\n, ( 2)\nre\nm ov\nes c\nhi ld\n\u2019s c\nlo th\nes ,\nem pt\nie s\npo ck\net s,\n(3 )\nho ld\ns AA\nI i n\npl ac\ne fo r 10 s (4 ) m as sa ge s sit e fo r 10 s , ( 5) p la ce s AA I in a s af e pl ac e af te r re m ov al , ( 6) . p ho ne 99 9. 4 w as d ev ic esp ec ifi c an d ta ke n fr om t he m an uf ac tu re r da ta sh ee t.\nO ve\nra ll,\n1 5%\no f\nm ot\nhe rs\nw er e un ab le t o \u201cfi re \u201d A AI . 12 a nd 3 2% o f m ot he rs pe rf or m ed a ll 10 s te ps su cc es sf ul ly w it h Ep ip en \u00ae a nd An ap en \u00ae , re sp ec ti ve ly . H ig he r pr op or ti on o f m ot he rs co rr ec tl y pe rf or m ed a ll An ap en \u00ae -s pe ci fic s te ps t ha n Ep ip en \u00ae ( O R 14 .2 4, P < 0 .0 00\n1)\nSt re\nng th : 1. L ar ge s\nam pl\ne si\nze w\nit h\nin cl\nus io\nn an\nd ex\ncl us\nio n\ncr it\ner ia\nc le\nar ly\nd efi\nne d.\n2.\nC om\npa re\nd tw\no br\nan ds\no f\nA AI\nus\ned in\nc lin\nic al\np ra\nct ic\ne.\n3. R\nes ul\nts o\nf ea\nch o\nf th\ne 10\nst\nep s\nin t\nhe e\nva lu\nat io n cl ea rl y la id o ut .\nLi m\nit at\nio ns : 1. N o fo llo\nw u\np ca\nrr ie\nd ou t 2. N ot p er fo rm ed s pe ci fic al\nly\non m\not he\nrs o\nf ch\nild re\nn w\nit h\na fo\nod a\nlle rg\ny.\n3. R\nem ov\nal o\nf c lo\nth es\na n\nun ne\nce ss\nar y\nst ep\nt o\nev al\nua te\n.\n(C on\nti nu\nes )\nTa bl\ne 5\nCo nt\nin ue\nd\nAu th\nor (\nYe ar ) Lo ca ti on Ti tl e\nO bj\nec ti\nve s\nPo pu\nla ti on sa m pl e si\nze St\nud y\nm et\nho do\nlo gy\nAs se\nss m\nen t\nto ol\nu se\nd Ke\ny fin\ndi ng\ns St\nre ng\nth s\nan d\nlim it\nat io\nns\nG ol\nd &\nS ai\nns bu\nry\n(2 00\n0) 3\nAu st\nra lia\nFi rs\nt ai d an ap hy\nla xi s m an ag em en t in c hi ld re n w\nho\nw er\ne pr\nes cr\nib ed\nan\ne pi\nne ph\nri ne\nau\nto in\nje ct\nor\nde vi\nce (\nEp ip\nen \u00ae )\nTo d\net er\nm in e pa re nt al kn ow le dg e an d A AI u se f or an ap hy la xi s m an ag em en t, th e fr eq ue nc y of r ec ur re nc e of a lle rg ic re ac ti on s, t he m ea su re s th at w er e ta ke n an d th ei r ou tc om es\nPa re\nnt s\nof\nch ild\nre n\nw it\nh a\nH x\nof\nan ap\nhy la\nxi s,\nw ho\nw\ner e\npr es\ncr ib\ned\nw it\nh an\nE pi\npe n\u00ae\nat\nte nd\ned a\npa\ned ia\ntr ic\na lle\nrg y\ncl in\nic b\net w\nee n\nJa n\n19 98\na nd\nJu\nne 1\n99 8.\n94\nTe le\nph on\ne in\nte rv\nie w\nw\nas c\non du\nct ed\nfo r\npa re\nnt s\nto a\nss es s th ei r kn ow le dg\ne on\nan\nap hy\nla xi\ns, A\nAI\nus e\nan d\nal le\nrg ic\nre\nac ti\non p\nre ve\nnt io n at h om e an d sc ho ol , al le rg ic r ea ct io ns si nc e pr es cr ip ti on o f Ep ip en \u00ae , t he s ym pt\nom s\nex pe\nri en\nce d,\nac\nti on\ns ta\nke n\nan d\nth ei\nr ou\ntc om\nes\n(h os\npi ta\nlis at\nio n)\n.\nFo ur\ne ss\nen ti\nal s\nte ps\nw\ner e\nus ed\nt o\nas se\nss\nA AI\nu se\n. (1\n) re\nm ov\nal\nof g\nre y\nca p\n(2 )\npl ac\nin g\nth e\nbl ac\nk en\nd on\nt he\nth\nig h\n(3 )\nap pl\nyi ng\npr\nes su\nre u\nnt il\na cl\nic k\nw as\nh ea\nrd (\n4) h\nol di\nng\nA AI\nin p\nla ce\nf or\n1 0\ns.\n24 %\nof p\nar en\nts c\nou ld\nr ec\nal l\nal l f\nou r\nst ep\ns. 8\n0% k\nne w\nt he\nad\nm in\nis tr\nat io\nn si\nte a\nnd t\no ap\npl y\npr es\nsu re\n. 50\n% re\nm ov\ned g\nre y\nca ps\na nd\nh el\nd in\np la\nce f\nor 1\n0 s.\nPa\nre nt\ns of\nc hi\nld re\nn w\nho h\nad\nex pe\nri en\nce d\na gr\nea te\nr nu\nm be r of a lle rg ic r ea ct io ns h ad a gr ea te r kn ow le dg e of A AI u se . 37 % of t ho se w ho se c hi ld re n ex pe ri en ce d tw o or m or e re ac ti on s pe rf or m ed a ll fo ur st ep s co m pa re d to 1 8% o f th os e w ho e xp er ie nc ed o ne o r fe w er re ac ti on s.\nSt re\nng th : 1. P op ul at\nio n\nre ce\niv ed\nt he\nsa\nm e\ned uc\nat io\nn re\nga rd\nin g\nA AI\nu se\na nd\na lle\nrg y\nkn ow\nle dg\ne pr\nio r\nto s\ntu dy . 2. S im pl e 4 st ep a ss es sm en t to ol f or E pi pe n\u00ae u se . 3. L in ks fi nd in gs r eg ar di ng A\nAI\nkn ow\nle dg\ne to\nu se\nd ur\nin g\nan ap\nhy la\nxi s\nLi m\nit at\nio ns : 1. A ss es sm\nen t\nof A\nAI\nco nd\nuc te\nd ov\ner t\nhe p\nho ne\nra\nth er\nt ha\nn fa\nce t\no fa\nce .\nJo ne\ns et\na l.\n(2\n01 5)\n5\nU K Fa ct\nor s\nas so\nci at\ned w\nit h\ngo od\na dh\ner en\nce\nto s\nel f-\nca re\nbe\nha vi\nou rs\nam\non g\nad ol\nes ce\nnt s\nw it h fo od a lle rg y\nTo u\nse t\nhe\nH ea\nlt h\nBe lie\nve\nM od\nel t\no ex\npl or e fa ct or s re la ti ng to s el fca re be ha vi ou rs am on g ad ol es ce nt s w it h fo od a lle rg ie s.\nAd ol\nes ce\nnt s\nag ed\n1 3\u2013\n19 y\nea rs , di ag no se d w it h a fo od a lle rg y an d pr es cr ib ed an A AI , w ho h av e at te nd ed o ne o r tw o pa ed ia tr ic ou tp at ie nt s\u2019 cl in ic s. 18 8\nA qu\nes ti\non na\nir e\nw as\ngi\nve n\nto p\nar ti\nci pa\nnt s\nw it\nh it\nem s\nba se d on t he H ea lt h\nBe lie f M od el . It c on ta in ed qu es ti on s re ga rd in g de m og ra ph ic s, al le rg y di ag no si s, kn ow le dg e on A AI us e, c on fid en ce w it h us in g an A AI , su pp\nor t,\nso\nci al\np sy\nch ol\nog ic\nal\nfa ct\nor s,\nh ea\nlt h\nbe lie\nfs ,\npe rc\nei ve d su sc ep ti bi lit y, pe rc ei ve d be ne\nfit s,\npe\nrc ei\nve d\nba rr\nie rs\nan\nd cu\nes t\no ac\nti on\n.\nAs se\nss ed\nw it\nh ni\nne\nqu es\nti on\ns re\nga rd\nin g\nan ap\nhy la\nxi s\nm an\nag em\nen t\nw it h pa rt ic ip an ts g et ti\nng\na sc\nor e\nou t\nof 9\nf or\nco\nrr ec\nt an\nap hy\nla xi s m an ag em en t. Q ue st io ns r el at ed to s ym pt om s of an ap hy la xi s, p re\npa ri\nng\nA AI\n( ch\nec k\nex pi\nry\nda te\n, re\nm ov\ne ca\np) ,\nad m\nin is\ntr at\nio n\n(h ol\ndi ng\nA AI\nc or\nre ct\nly ,\nth ro\nug h\ncl ot\nhi ng , in je ct io n si te , le\nng th\nof\nt im\ne to\nh ol\nd A\nAI in\npl\nac e)\na nd\nf ol\nlo w\n-u p\nca re\n.\nM ea\nn of\n7 .7\n8/ 9\nsc or\ne fo\nr A\nAI\nkn ow\nle dg\ne.\n18 %\nco ul\nd id\nen ti\nfy a\nll th\ne ni\nne\nst ep\ns co\nrr ec\ntl y.\nPo\nor es\nt le\nve l o\nf kn\now le\ndg e\nin\nkn ow\nin g\nho w\nt o\nho ld\nt he\nA AI\n(4\n4% in\nco rr\nec t)\na nd\na lw\nay s\nse ek\nin g\nm ed\nic al\na tt\nen ti\non a\nft er\nus\nin g\nA AI\n( 32\n% in\nco rr\nec t)\nKn ow\nle dg\ne of\nA AI\nu se\nn ot\nas\nso ci\nat ed\nw it\nh ad\nol es\nce nt\nse\nlfad\nhe re\nnc e.\nSt re\nng th : 1. S im pl e\nni ne\n-m ar\nk sc\nor in g sy st em t o as se ss A AI u se .\n2. A\nss es\nse d\nal l a\nsp ec\nts o f A AI u se , in cl ud in g be\nfo re\n(r\nec og\nni si\nng s\nym pt\nom s)\ndu\nri ng\n( co\nrr ec\nt A\nAI\nad m\nin is\ntr at\nio n)\na nd\na ft\ner\n(s ee\nki ng\nm ed\nic al\na tt\nen ti\non ).\n3.\nS tu\ndi es\na ss\noc ia\nti on\ns of\nA\nAI k\nno w\nle dg\ne w\nit h\not he r ps yc ho lo gi ca l a nd s oc ia l fa ct or s re la ti ng t o ha vi ng\na\nfo od\na lle\nrg y.\nLi m\nit at\nio ns : 1. L ow r es\npo ns\ne ra\nte t o qu es ti on na ir e (3 4%\n) po\nss ib\nle\nre sp\non de\nr bi\nas .\n2. K\nno w\nle dg\ne as\nse ss\ned w\nit h\na qu\nes ti\non na\nir e\nw it\nh no\nde\nm on\nst ra\nti on . 3. B ra nd o f A AI p\nre sc\nri be\nd no t sp ec ifi ed in q ue st io nn ai re .\nKa po\nor e\nt al . (2 00 4) 6 U K In flu en ce o f a m ul ti di sc ip lin\nar y\npa ed\nia tr\nic\nal le\nrg y\ncl in\nic\non p\nar en\nta l\nkn ow\nle dg e an d ra te o f su bs eq ue nt al le rg ic re ac ti on s.\nTo a\nss es\ns th e im pa ct o f m ul ti di sc ip\nlin ar y al le rg y co ns ul ta ti on in a sp ec ia lis ed al le rg y cl in ic on p ar en ta l kn ow le dg e of fo od a lle rg y an d th e ra te of s ub se qu en t al le rg ic re ac ti on s.\nPa re\nnt s\nan d\nch ild\nre n\nag ed\n<1\n7 ye\nar s\nw ho\nat\nte nd\ned a\nsp\nec ia\nlis ed\nal\nle rg\ny cl\nin ic\na nd\nw\ner e\ndi ag\nno se d w it h a fo od al le rg y. 62\nBe fo\nre a\ntt en\ndi ng\nth\ne cl\nin ic\n, pa\nre nt s co m pl et ed a qu es ti on na ir e re ga rd in g al le rg en av oi da nc e, an ap hy la xi s m an ag em en t an d H x of a lle rg ic r ea ct io ns . Pa re nt s an d ol de r ch ild re n w er e as ke d to d em on st ra te t he us e of E pi pe n\u00ae . Ch ild re n w er e as se ss ed b y an a lle rg y sp ec ia lis t, a nd a n al le rg y m an ag em en t pl an w as s et u p fo r th em . A cl in ic al nu rs e sp ec ia lis t ed uc at ed t he ch ild re n an d pa re nt s on a na ph yl ax is m an ag em en t pl an an d ho w t o us e an Ep ip en \u00ae . A sp ec ia lis t di et ic ia n co ns ul te d th em o n fo od a lle rg en av oi da nc e. Pa re nt s fil le d in t he sa m e qu es ti on na ir e an d de m on st ra te d Ep ip en \u00ae u se at a f ol lo w -u p ap po in tm en t 3 m on th s la te r an d re vi ew ed 1 y ea r la te r.\nPa re\nnt s\nan d\nol de r ch ild re n w er e as ke d to d em on st ra te Ep ip en \u00ae u se p ri or t o an d 3 m on th s af te r co ns ul ta ti on . Th re e st ep s w er e id en ti fie d as b ei ng cr it ic al f or E pi pe n\u00ae us e: (1 ) re m ov al o f gr ey s af et y ca p (2 ) se le ct in g ap pr op ri\nat e\nsi te\na nd\n( 3)\np re\nss in g Ep ip en \u00ae d ow n un ti\nl a\n\u201cc lic\nk\u201d is\nh ea\nrd .\nBe fo\nre c\non su\nlt at\nio n:\n6 0.\n7%\nof t\nhe f\nam ili\nes h\nad r\nec ei\nve d\na de\nm on\nst ra\nti on\no n\nho w\nt o\nus e\nth ei\nr Ep\nip en\n\u00ae .\n50 %\nco ul d id en ti fy a ll th e th re e cr it ic al st ep s, a nd t he re w as n o di ff er en ce in t ho se r ef er re d fr om p ri m ar y or s ec on da ry\nc ar\ne.\nAf te\nr co\nns ul\nta ti\non :\n95 .7\n% of\nt he\nfa\nm ili\nes c\nou ld\nid en\nti fy\na ll\nth e\nth re\ne cr\nit ic\nal s\nte ps\n, w\nit h\nan\nim pr\nov em\nen t\nof 8\n3. 3%\n. Si\nm ila r im pr ov em en ts w er e se en in fa m ili es r ef er re d fr om b ot h pr im ar y an d se co nd ar y ca re . Th er e w er e al so s ig ni fic an t im pr ov em en ts in p ar en ta l kn ow le dg e of a lle rg en a vo id an\nce\n(2 6.\n9% )\nan d\nin m\nan ag\nem en t of a lle rg ic r ea ct io ns (1 85 .4\n%) .\nTh es\ne im\npr ov\nem en\nts w\ner e\nas so\nci at\ned w\nit h\na si\ngn ifi\nca nt\nre\ndu ct\nio n\nin a\nlle rg\nic r\nea ct\nio ns\n.\nSt re\nng th : 1. A ss es sm\nen t\nof A\nAI u\nse\nbe fo\nre a\nnd a\nft er\na n\ned uc\nat io\nna l i\nnt er\nve nt\nio n\nby\nan a\nlle rg\ny sp\nec ia\nlis t.\n2.\nC le\nar o\nut lin\ne of\nin te\nrv en\nti on\nca\nrr ie\nd ou\nt.\n3. A\nss oc\nia ti\non o\nf Ep\nip en\n\u00ae\nkn ow\nle dg\ne w\nit h\nin ci\nde nc\ne of\nal\nle rg\nic r\nea ct\nio ns . Li m it at io ns : 1. S m al l s am pl e si ze\no f\npa re\nnt s\nas se\nss ed\nf or\nA AI\nu se\n( n = 23 ).\n(C on\nti nu\nes )\nTa bl\ne 5\nCo nt\nin ue\nd\nAu th\nor (\nYe ar ) Lo ca ti on Ti tl e\nO bj\nec ti\nve s\nPo pu\nla ti on sa m pl e si\nze St\nud y\nm et\nho do\nlo gy\nAs se\nss m\nen t\nto ol\nu se\nd Ke\ny fin\ndi ng\ns St\nre ng\nth s\nan d\nlim it\nat io\nns\nRo bi\nns on\ne t\nal .\n(2 01\n4) 8\nAu st\nra lia\nCo m\npa ri\nso n\nof a\ndr en\nal in e au to in je ct or de vi ce s: E as\ne of\nus\ne an\nd ab\nili ty\nt o\nre ca\nll us\ne\nTo c\nom pa\nre t\nhe\nin tu\nit iv\nen es s of t he u se o f Ep ip en \u00ae a nd An ap en \u00ae d\nev ic\nes\nan d\nth e\nab ili\nty\nto r\nec al\nl t he\nu se\nof\nt he\nse d\nev ic\nes\naf te\nr 3\nm on\nth s.\nVi si\nto rs , pa re nt\ns an d st aff a tt en\ndi ng\na\nch ild\nre n\u2019 s ho sp it al o\nve r a 3- m on th p er io\nd,\nw ho\nh ad\nn ot\nre\nce iv\ned p\nri or\ntr\nai ni\nng in\nt he\nus\ne of\nE pi\npe n\u00ae\no r\nAn ap\nen \u00ae .\n10 0\nPa rt\nic ip\nan ts\nw er e ra nd om is ed t o be ev al ua te d w it h An ap en \u00ae ( n = 53 )\nor\nEp ip\nen \u00ae (\nn =\n47 ).\nPa\nrt ic\nip an\nts\nw er\ne gi\nve n\n2 m\nin\nto f\nam ili\nar is e th em se lv es\nw it\nh th e de vi ce b ef or e be in g as se ss ed . Pa rt ic ip an ts r ec ei ve d tr ai ni ng o n th e us ag e of A AI b y an a lle rg is\nt,\nan d\nth ey\nw er\ne as\nke d\nto d\nem on\nst ra\nte t\nhe\nus e\nof t\nhe d\nev ic e im m ed ia te ly a\nft er . 32 p at ie nt s w er e co nt ac te d 3 m on\nth s\nla te\nr an\nd as\nke d\nto\nde m\non st\nra te\nt he\nu se\nof\nt he\nA AI\n.\nCr it\nic al\ns te\nps in\nEp\nip en\n\u00ae :\n(1 )\nre m\nov al\no f\nbl ue\nsa\nfe ty\nc ap\ns (2 ) or an ge c ap o n\nup pe r an d ou te r th ig hs ( 3) do w nw ar d pr es su re t o ac ti va te . Cr it ic al s te ps in An ap en \u00ae : (1 ) re m ov al o f gr ey sa fe ty c ap ( 2) r em ov al of b la ck c ap c ov er in g th e ne ed le ( 3) b la ck ne ed le e nd o n th ig h (4 ) pu sh in g re d bu tt on to a ct iv at e. Al so , se le ct t he u pp er an d ou te r th ig hs a nd ho ld A AI f or 1 0 s.\n84 %\nco rr\nec tl\ny de\nm on\nst ra\nte d\nth e\nus e\nof t\nhe A\nAI w\nit h\nno p\nre vi\nou s\ntr ai\nni ng\n, an\nd no\ns ig\nni fic\nan t\ndi ff\ner en\nce s\nw er\ne ob\nse rv\ned\nbe tw\nee n\nth e\nde vi\nce s.\n1 00 % co rr ec tl y us ed t he A AI a ft\ner\nre ce\niv in\ng in\nst ru\nct io\nn.\nAf te\nr 3\nm on\nth s,\na bi\nlit y\nto r\nec al l th e us e of A na pe n\u00ae w as lo w er th an t ha t of E pi pe n\u00ae ( 35 % vs 87 %, r es pe ct iv el y) . Cr it ic al e rr or s w er e m or e co m m on in A na pe n\u00ae t ha n in E pi pe n\u00ae ( 59 % vs 1 3% , re sp ec ti ve ly ), w it h th e m os t co m m on c ri ti ca l m is ta ke b ei ng m ad e in A na pe n\u00ae , w hi ch w as fa ilu re t o pu sh t he r ed b ut to n to ac ti va te .\nSt re\nng th : La rg e sa m\npl e\nsi ze\n( n\n= 10 0) In cl us io n an d ex cl us io n cr\nit er\nia\ncl ea\nrl y\nou tl\nin ed . Sp ec ifi c er ro rs\nin e\nac h\nde vi\nce\nou tl\nin ed . Li m it at io\nns :\nSm al\nl s am\npl e\nsi ze\nin f\nol lo\nw -u p st ud y (n = 3 2) Al lo w ed 2 m in p ri or t o as se ss m en t to f am ili ar is e th em se lv es w it h th e pe n.\nSe ga\nl e t\nal .\n(2 01\n2) 11\nIs ra el Eff ec t\nof\nIn st\nru ct\nio n\non t\nhe a\nbi lit y to u se a s el fad m in is te re d ep in ep hr in e in je ct or\nTo e\nva lu\nat e\nth e\nkn ow\nle dg e on A AI u sa ge in p ar en ts a nd pa ti en ts w it h al le rg ie s af te r an in it ia l c lin ic vi si t an d as se\nss\nth e\nbe ne\nfit o f re in st ru ct io n in t he u se o f Ep ip en \u00ae a t a fo llo w -u p vi\nsi t.\nCh ild\nre n\nan d\nad ol\nes ce\nnt s\nan d\nth ei\nr pa\nre nt s at te nd in g an al le rg y cl in\nic w\nho\nha d\nex pe\nri en\nce d\nan ap\nhy la\nct ic\nre\nac ti\non s\nan d\nw er\ne di\nag no\nse d\nw it\nh an\nE pi\npe n\u00ae . 14 1\nPa ti\nen ts\na nd\npa\nre nt\ns w\ner e\ngi ve n w ri tt en e m er ge nc y an ap hy la xi s pl an s\nan d\nw ri\ntt en\nin st\nru ct\nio n\non\nho w\nt o\nus e\nEp ip\nen \u00ae\nan d\ntr ai\nne d\nin it\ns us e by a c lin ic ia n. At t he n ex t fo llo w -u p vi si t, p ar ti ci pa nt s w er e gi ve n a qu es ti on na ir e on in di ca ti on s fo r us e of an E pi pe n\u00ae a nd w er e as ke d to d em on st ra te\nEa ch\ns te\np of\nt he\npr\noc ed\nur e\nw as\ng iv\nen a\nsc\nor e\nbe tw\nee n\n0 an d 2, w it h a m ax im um po ss ib le s co re o f 10 . 0 m ea nt t ha t th e pa rt ic ip an t di d no t kn ow t o do t hi s. 1 m ea nt t ha t th ey he si ta te d fo r a pe ri\nod\nbe fo\nre c\nom pl\net in\ng th e st ep . 2 m ea nt t ha t th e st ep w as p er fo rm ed co rr ec tl y w it ho ut he si ta ti on .\n37 .5\n% of\np ar\nti ci\npa nt\ns fa\nile d\nto\nre m\nov e\nth e\nca p\n(S te\np 1) . 62 \u20138 7% in co rr ec tl y pe rf\nor m\ned\nSt ep\ns 4\nan d\n5.\n19 %\nre ce\niv ed\na s\nco re\no f\n0.\nEi gh\nt (5\n.6 %)\ns co\nre d\na m\nax im\num\n10 w\nit h\na m\nea n\nof 4\n.0 3\n\u00b1 3.\n41\np ar\nti ci\npa nt\ns w\ner e\nre -e\nva lu\nat ed\na ft\ner 1\n.0 2\n\u00b1 0.\n56\nye ar\ns. T\nhe m\nea n\nsc or\ne of\nt hi s su bg ro up im pr ov ed f ro m 4 .7\n1 \u00b1\n3. 04\nt o\n6. 7\n\u00b1 3.\n18 (\nP <\n0. 00\n1) .\nSt re\nng th : La rg e sa m\npl e\nsi ze\n( n\n= 14 1) As se ss m en t to ol c le ar ly de fin ed . Li m it at io ns : N ei th er s tr en gt hs n or lim it at io ns w er e di sc us se d. Re co m m en da ti on s fo r fu\nrt he r re se ar ch w er e no t di sc us se d.\nit s\nus e\nw it\nh a\ntr ai\nne r\npe n. So m e\npa rt\nic ip\nan ts\nw\ner e\nas ke\nd to\nr ep\nea t\nth e\nde m\non st\nra ti\non a t a se co nd f ol lo w -u p vi si t.\nSt ep\ns: (1\n) Re\nm ov\ne th e ca p (2 ) ho ld in g th e de vi ce ( 3) p la ci ng o n th ig h an d pr es si ng un ti l a c lic k is h ea rd (4 ) ho ld in p la ce f or 1 0 s (5 ) m as sa ge in je ct io n si te .\nSi ch\ner er\ne t\nal .\n(2 00\n0) 9\nU SA U se\nA ss\nes sm\nen t\nof S\nel f-\nAd m\nin is\nte re d Ep in ep hr in e Am on g Fo od - Al le rg ic Ch ild re n an d Pa ed ia tr ic ia\nns\nTo d\net er\nm in e th e ab ili ty o f fa m ili es w it h fo od a lle rg ic ch ild re n an d pa ed ia tr ic ia\nns t o co rr ec tl y us e an A AI .\nFa m\nili es\no f n\new ly\nre\nfe rr\ned fo\nod\nal le\nrg ic\np ae\ndi at\nri c\npa ti\nen ts\nw ho\nw er e pr es cr ib ed a n AA I. A sa m pl e of pa ed ia tr ic ia ns at a p ae di at ri c am bu la to ry c ar e fa ci lit y an d fiv e pr iv at e cl in ic s affi lia te d w ith t he sa m e ho sp it al . 10 1 fa m ili es . 2 9 pa ed ia tr ic ia ns .\nPa re\nnt s\nor t\nee na\nge\npa ti\nen ts\nc om\npl et\ned\na qu\nes ti\non na\nir e\nre ga\nrd in g de m og\nra ph\nic s\nan d\nth e\nus e\nof\nse lf-\nad m\nin is\nte re d ad re na lin e. Th ey w er e th en\na sk\ned\nto d\nem on\nst ra\nte t\nhe\nus e\nof t\nhe A\nAI w\nhi ch\nth\ney w\ner e\nfa m\nili ar\nw\nit h.\nEp ip\nen \u00ae u\nse w\nas s\nco re d ou t of s ix s te ps b as ed on t he in st ru ct io ns su pp lie d by t he m an uf ac tu re r. (1 ) r ec og ni se s th e de vi ce w ith ou t ex am in in g fo r cl ue s as t o ho w t o us e it (2 ) re m ov e ca p (3 ) s el ec t ap pr op ri at e bo dy s ite (4 ) p re ss t he c or re ct en d of t he d ev ic e to b od y (5 ) p re ss t o ac ti va te 6 ) h ol d in p la\nce\nfo r\nse ve\nra l s\nec on\nds .\n32 %\nof t\nhe p\nar ti\nci pa\nnt s\nde m\non st\nra te\nd th\ne us\ne of\nt he\nA\nAI c\nor re\nct ly . Th e st ep s w hi\nch a\ncc ou\nnt ed\nf or\nth\ne gr\nea te\nst n\num be\nr of\nm is\nta ke s w er e re m ov in g th e sa fe ty c ap (3 0% in co rr ec t) , pr es si ng t o ac ti va te t he n ee dl e (c lic k) (4 0% in co rr ec t) a nd h ol di ng th e de vi ce in p la ce f or s ev er al se co nd s (4 5% in co rr ec t) .\nSt re\nng th : La rg e sa m\npl e\nsi ze\n( n\n= 10\n1) .\nEx te\nns iv\ne st\nud y\nof p\nar en t an d pa ti en t ch ar ac te ri st ic s to d et er m in e th ei r po ss ib le as so ci at io ns w it h A AI u se Li m it at io ns : Re su lt s no t cl ea rl y ou tl in ed . N ei th er s tr en gt hs n or lim it at io ns w er e di sc us se d. Re co m m en da ti on s fo r fu rt he r re se ar ch w er e no t di sc us se d.\nSi ch\ner er\ne t\nal .\n(2 01 2) U SA D ev el\nop m\nen t\nan d\nva lid\nat io n of e du ca ti on al m at er ia ls f or fo od a lle rg y\nTo d\nev el\nop\nan d\nva lid\nat e\na fo\nod a\nlle rg y ed uc at io na l pr og ra m m e fo r pa re nt s.\nCo nv\nen ie\nnc e\nsa m\npl e\nof\nfa m\nili es\npr\nes en\nti ng\nf or\nth\nei r\nfir st\nv is\nit\nto t\nw o\nal le\nrg y\ncl in\nic s\nw ho\nw er e pr es cr ib ed a n A AI . 60\nEd uc\nat io\nna l m\nat er\nia ls\nw\ner e\nde ve\nlo pe d th ro ug h fo cu s\ngr ou\nps ,\nan d\npa re\nnt al\na nd\nex\npe rt\nr ev\nie w\ns.\nPa re\nnt s\nw er e as ke d to c\nom pl\net e\na de\nm og\nra ph\nic s\nqu es\nti on\nna ir e an d fo od a\nlle rg y kn ow le dg e te st . A AI a dm in is tr at io n w as a ss es se d be fo re a nd a ft er th e ed uc at io na l in te rv en ti on . At 1 y ea r, t he p\nar en\nts\nw er\ne re\n-e va\nlu at\ned .\nA AI\nc om\npe te\nnc y\nw as\ns co\nre d\nou t\nof a\nm\nax im\num o\nf so\nx ba\nse d\non t\nhe f\nol lo\nw in\ng st\nep s:\n(1\n) re\nco gn\nis es\nd ev\nic e\nw it\nho ut\nlo ok\nin g\nfo r\ncl ue\ns as\nt o\nho w\nt o\nus e\nit (\n2) r\nem ov\ne ca p (3 ) co rr ec t si te ( 4) co rr ec t en d (5 ) pr es s to a ct iv at e (6 ) ho ld f\nor\nse ve\nra l s\nec on\nds .\n18 %\npe rf\nor m\ned a\nll si\nx st\nep s\nco rr\nec tl\ny pr\nio r\nto t\nra in\nin g.\nT hi s in cr ea se d to 9 5% a ft er t ra in in g (m ea n sc or es in cr ea se d fr om\n3 .4\nto\n5 .9\n5, P\n< 0\n.0 01\n).\nTh e\nm ea\nn sc\nor e\nde cl\nin ed\nt o\n5. 47\naf\nte r\n1 ye\nar ,\nst ill\ns ig\nni fic\nan tl y ab ov e ba se lin e, w it h tw o su bsc or es d ec re as in g si gn ifi ca nt ly , na m el y re co gn iz in g th e de vi ce an d ho ld in g th e de vi ce in p la ce fo r se ve ra l s ec on ds . Co m fo rt in u si ng t he A AI w as ba se d on a s ca le o f 1 (n ot co m fo rt ab le a t al l) to 7 ( to ta lly co m fo rt ab le ). T he m ea n sc or e at b as el in e w as 4 .6 3 an d in cr ea se d to 6 .2 3 af te r th e in te rv en ti on a nd r em ai ne d el ev at ed a t 1 ye ar ( 6. 03 ).\nSt re\nng th : As se ss\nm en\nt to\nol u\nse d\nin s\ntu dy\nin\ncl ud\ned .\nD et\nai le\nd su\nm m\nar y\nof\npo pu\nla ti\non d\nem og\nra ph\nic s.\nCl ea\nr ou\ntl in\ne of\ne du\nca ti\non al\nin\nte rv\nen ti\non u\nse d.\nLi\nm it\nat io\nns :\nA AI\na ss\nes se\nd w\nas n\not\nid en\nti fie\nd.\nSm al\nl s am\npl e\nsi ze\n( n\n= 60\n)\n(C on\nti nu\nes )\nTa bl\ne 5\nCo nt\nin ue\nd\nAu th\nor (\nYe ar ) Lo ca ti on Ti tl e\nO bj\nec ti\nve s\nPo pu\nla ti on sa m pl e si\nze St\nud y\nm et\nho do\nlo gy\nAs se\nss m\nen t\nto ol\nu se\nd Ke\ny fin\ndi ng\ns St\nre ng\nth s\nan d\nlim it\nat io\nns\nU m\nas un\nth ar\ne t\nal .\n(2 01 5) U K Pa ti en ts \u2019 ab ili ty t\no tr\nea t\nan ap\nhy la\nxi s\nus in\ng ad\nre na\nlin e\nau to\nin je\nct or\ns:\nA ra\nnd om\nis ed\nco\nnt ro\nl t ri\nal .\nTo e\nva lu\nat e\nth e\nab ili\nty o f m ot he rs o f fo\nod -\nal le\nrg ic\nc hi\nld re n to s uc ce ss fu lly us e an A AI in a si m ul at ed an ap hy la xi s sc en ar io a nd t o co m pa re s uc ce\nss\nra te\ns in\nm ot\nhe rs\nal\nlo ca\nte d\nto\ndi ff\ner en\nt A\nAI\nde vi\nce s.\nM ot\nhe rs\no f\nch ild\nre n\nw it\nh a\nfo od\na lle\nrg y\nan d\npr es\ncr ib\ned a n A AI a tt en di ng a sp ec ia lis t pa ed ia tr ic a lle\nrg y\nce nt\nre .\n20 0\nPa rt\nic ip\nan ts\nw er e ra nd om ly a llo ca\nte d\nto\nbe t\nra in\ned in\ne it\nhe r\nAn ap\nen \u00ae o\nr Ep\nip en\n\u00ae .\nA AI\na dm\nin is\ntr at\nio n\nan d\n6 w\nee ks\na nd\n1\nye ar\na ft\ner in\nit ia l tr ai ni ng . At 1 y ea r, p ar ti ci pa\nnt s\nw er\ne al\nlo ca\nte d a ne w d ev ic e (E\npi pe\nn\u00ae ,\nAn ap\nen \u00ae ,\nne w\nEp\nip en\n\u00ae ,\nJe xt\n\u00ae o r Au vi -Q \u00ae ), a nd t he\nir\nab ili\nty t\no us\ne th\ne ne\nw\nA AI\nw as\na ss\nes se d w it ho ut p ri or d ev\nic e-\nsp ec\nifi c\ntr ai\nni ng\n.\nFo ur\nk ey\ns te\nps w\ner e\nid en\nti fie\nd fo\nr su\ncc es s of A AI a dm in is tr at io n: (1 ) re m ov al o f sa fe ty ca ps ( 2) p la ce m en t of co rr ec t en d of d ev ic e ag ai ns t th e th ig h (3 ) ac ti va ti on o f de vi ce (4 ) ho ld in g de vi ce in pl ac e fo r >5 s . Pr im ar y re as on f or fa ilu re w as d efi ne d us in g a hi er ar ch y of sa fe ty c ap (s ) > co rr ec t de vi ce p os it io ni ng > de vi ce a ct iv at io n > he ld in p la ce f or su ffi ci en t ti m e.\nN o\nsp ec\nifi c\ndi ff\ner en\nce in\ns uc\nce ss\nra\nte s\nbe tw\nee n\nEp ip\nen \u00ae a\nnd\nAn ap\nen \u00ae a\nt 6\nw ee\nks a\nnd 1\ny ea\nr.\nAt 1\ny ea\nr, A\nna pe\nn\u00ae u\nse rs\nw er e m or e lik el y to f ai l t o re m ov e\nth e\nsa fe\nty c\nap ,\nw hi\nle E\npi pe\nn\u00ae u\nse rs\nw\ner e\nm or\ne lik\nel y\nto u\nse t\nhe\nin co\nrr ec\nt en\nd of\nt he\nd ev\nic e.\nD\niff er\nen ce\nin s\nuc ce\nss r\nat es\nfo\nr pa\nrt ic\nip an\nts s\nw it\nch ed\nt o a tw oca p de vi ce ( An ap en \u00ae )\nfr om\na\nsi ng\nle -c\nap d\nev ic\ne (E\npi pe\nn\u00ae ,\nN ew\nE pi\npe n\u00ae\n, Je\nxt \u00ae ,\nAu vi\n-Q \u00ae )\nor\nvi ce\nv er\nsa (\n36 %)\nc om\npa re\nd w\nit h\npa rt\nic ip\nan ts\ns w\nit ch\ned b\net w\nee n\ndi ff\ner en\nt si\nng le\n-c ap\nd ev\nic es\n(7\n8% ).\nSt re\nng th : La rg e sa m\npl e\nsi ze\n( n\n= 15 8) Al l r es ul ts c le ar ly o ut lin ed H ie ra rc hy o f fa ilu re in A AI st ep s Li m it at io ns : In cl us io n an d ex cl us io n cr it\ner ia\nno\nt cl\nea rl\ny ou\ntl in\ned\ncause the failure of adrenaline administration, a limitation in this study\u2019s analysis. A limitation of the second study8 was that the study population consisted of parents who were not familiar with the usage of AAI, and they were given only 2 min to familiarise themselves with using the AAI before assessment. Therefore, the findings may not represent the population of parents who are familiar with AAI devices but those who have not been given the chance to study in detail themselves how to use it, especially as this would not reflect a real emergency. There were no significant differences found between caregiver and adolescent patient AAI use, and the average score was 7.78/9.5 However, a significant limitation in this study was that AAI technique was assessed with a set of multiple-choice questions, which was less accurate than the demonstration of AAI use.5\nThe wide range of reported AAI ability may be due to the varied tools to assess AAI use in their respective populations, as shown in Table 6. Lower quality articles failed to address those steps in AAI administration which the participants failed to do,4 assessed AAI administration over the phone3 or used a multiple-choice questionnaire.5 Another lower quality study11 emphasised the failure of many caregivers to perform the final two steps in the assessment (hold in place for 10 s, massage site after injection) which do not indicate that adrenaline administration had failed. Part of assessment included whether parents failed to remove clothes before injection, which in fact is an unnecessary step in AAI administration and may prolong the administration of adrenaline.12 Studies of higher quality assessed AAI administration by using tools which evaluated fewer steps,6,7 used device-specific steps for successful administration6,8 and identified steps which were \u201ccritical\u201d to the administration of adrenaline, which would result in an automatic failure of adrenaline administration.7,8\nAll five studies, which evaluated the effectiveness of educational intervention on AAI use,6\u20138,10,11 found that AAI administration improved significantly. Three of the five studies6,8,10 assessed the AAI ability prior, immediately after and several months after receiving the intervention. This method showed the long-term impact of the educational intervention on AAI delivery technique, and in all studies, AAI ability was above baseline even up to a year after the initial training. However, in one case,8 baseline results were already high as the parents were allowed to familiarise themselves with the pen for 2 min before assessment,\nIn a study on AAI administration, it was found that successful AAI administration declined after switching to a new brand without receiving training (73.1\u201365.7%).7\nFactors which affect adrenaline autoinjector administration technique\nDifferences in AAI design were discussed in three studies.2,7,8 A higher proportion of mothers correctly performed all Anapen\u00ae-specific steps (32%) than Epipen\u00ae (12%).2 This contrasts with the findings of another study,8 where it was observed that significantly more participants correctly demonstrated Epipen\u00ae use (87%) compared to Anapen\u00ae (35%) 3 months after training, and critical errors were more common with Anapen\u00ae (59% vs 13%, P = 0.01). When switching to a new device without training, difference in success rates for participants switched to a two-cap device (Anapen\u00ae) from a single-cap device (Epipen\u00ae, New Epipen\u00ae, Jext\u00ae, Auvi-Q\u00ae) or vice versa (36%) when compared with participants switched between different single-cap devices (78%).7\nThe other factors observed by some studies which were found to significantly influence the ability of participants to administer an AAI included demonstration by a specialist allergist compared to a specialist or general practitioner {5.7 [2.0\u201316.3] vs 2.0 [0.9\u20134.9] odds ratio [95% confidence interval (CI)], respectively}4 and membership in a lay organization or support group for allergy [4.4 (2.0\u20139.6) odds ratio (95% CI)].4 Previous severe allergic reactions [1.0 (0.3\u201313.7) odds ratio (95% CI)]4 and time elapsed since last demonstration of AAI use [<12 months vs >24 months; 4.8 (1.6\u201313.7) vs 4.8 (1.6\u201313.7) odds ratio (95% CI]4 were not found to relate to the ability in AAI use."
        },
        {
            "heading": "Summary of results",
            "text": ""
        },
        {
            "heading": "Discussion",
            "text": "Findings on ability to use an AAI varied significantly, the success rates ranged from 5.6 to 84%.8,11 However, the former low maximum success rate of the above study11 is caused by the significantly high proportion (87%) of those who failed to massage the site after injection, a step which does not\nmonths after the intervention was given. This highlights the need for improved education for allergic individuals and their caregivers, and further study should explore what are the best educational methods to meet these needs. Finally, AAI administration ability varied among different AAI devices; therefore, as more AAI brands come to the market, device switches could become a significant clinical issue,7 and the rate of device switches and the effect this has on the ability to administer an AAI in an emergency should be investigated."
        },
        {
            "heading": "Future perspective",
            "text": "The introduction of new technologies including new ways to administer adrenaline for anaphylaxis in the following years could drastically change the way that we use adrenaline autoinjector devices.13"
        },
        {
            "heading": "Conclusion",
            "text": "Children are reliant on their parents to take responsibility of their allergy, to recognise the signs and symptoms of anaphylaxis, and to deliver adrenaline promptly.2 The review of parents\u2019 and patient\u2019s ability to use an AAI was inconclusive, and further research should address the validation of an assessment tool for AAI use. However, a significant improvement in AAI use was found after an educational intervention, and this improvement was still seen\nA pp\nen di\nce s\nA pp\nen di\nx A\n: EB\nL Cr\nit ic\nal A\npp ra\nis al\nC he\nck lis\nt\nEB L\nCr it\nic al\nA pp\nra is\nal C\nhe ck\nlis t\nAr kw\nri gh t & F ar ra gh\ner\n(2 00\n6) 4\nBr ow n et a l. (2 01 3)\n2\nG ol\nd &\nSa\nin sb\nur y\n(2\n00 0)\n3\nJo ne s et a l. (2 01 5)\n5\nKa po\nor ,\nS.\net a l (2\n00 4)\n6\nRo bi\nns on\net\na l.\n(2\n01 4)\n8\nSe ga l et a l. (2 01 2)\n11\nSi ch\ner er\net\na l.\n(2\n00 0)\n9\nSi ch\ner er\net\na l.\n(2\n01 2)\n10\nU m\nas un\nth ar\net\na l.\n(2\n01 5) 7\nSection A: Population\nIs t\nhe s\ntu dy\np op\nul at\nio n\nre pr\nes en\nta ti\nve o\nf al\nl u se\nrs ,\nac tu\nal a\nnd e\nlig ib\nle ,\nw ho\nm ig\nht b\ne in\ncl ud\ned in\nt he\nst\nud y?\nY Y\nY U\nY Y\nY Y\nY Y\nAr e\nin cl\nus io\nn an\nd ex\ncl us\nio n\ncr it\ner ia\nd efi\nni ti\nve ly\nou\ntl in\ned ?\nY N\nN N\nY Y\nN N\nY Y\nIs t\nhe s\nam pl\ne si\nze la\nrg e\nen ou\ngh f\nor s\nuffi ci\nen tl y pr ec is e es ti m at es\n? Y\nY Y\nY Y\nY Y\nY Y Y Is t he r es po ns e ra te la rg e en ou gh f or s uffi ci en tl y pr ec is e es ti m at es ? Y Y N Y Y Y Y Y Y Y Is t he c ho ic e of p op ul at io n bi as -f re e? Y N Y Y Y Y Y Y U Y If a c om pa ra ti ve s tu dy : 1. W er e pa rt ic ip an ts r an do m is ed in to g ro up s? 2. W er e th e gr ou ps c om pa ra bl e at b as el in e? a. If g ro up s w er e no t co m pa ra bl e at b as el in e, w as in co m pa ra bi lit y ad dr es se d by t he a ut ho rs in t he an al ys is ? Y Y Y N/ A Y N/ A Y N/ A N/ A - N/ A N/ A Y W as in fo rm ed c on se nt o bt ai ne d? U Y Y Y Y Y U Y Y Y\nSection B: Data Collection\nAr e\nda ta\nc ol\nle ct\nio n\nm et\nho ds\nc le\nar ly\nd es\ncr ib\ned ?\nY Y\nY Y\nY Y\nY Y\nY Y\nIf a\nf ac\neto\n-f ac\ne su\nrv ey\n, w\ner e\nin te\nrob\nse rv\ner a\nnd\nin tr\naob\nse rv\ner b\nia s\nre du\nce d?\nN/ A\nU U\nY N/\nA U\nU U\nU Y\nIs t\nhe d\nat a\nco lle\nct io\nn in\nst ru\nm en\nt va\nlid at\ned ?\nU U\nU U\nY Y\nN Y\nN/ A U If b as ed o n re gu la rl y co lle ct ed s ta ti st ic s, a re t he st at is ti cs f re e fr om s ub je ct iv it y? N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A N/ A\nN/ A\nD oe\ns th\ne st\nud y\nm ea\nsu re\nt he\no ut\nco m\ne at\na t\nim e\nap pr\nop ri\nat e\nfo r\nca pt\nur in\ng th\ne in\nte rv\nen ti\non \u2019s\ne ff\nec t?\nN/ A\nY N/\nA N/\nA N/\nA Y\nY N/\nA Y Y Is t he in st ru m en t in cl ud ed in t he p ub lic at io n? Y Y Y Y Y Y N Y Y Y Ar e qu es ti on s po se d cl ea rl y en ou gh t o be a bl e to el ic it p re ci se a ns w er s? Y Y Y Y Y Y Y Y Y Y W er e th os e in vo lv ed in d at a co lle ct io n no t in vo lv ed in de liv er in g a se rv ic e to t he t ar ge t po pu la ti on ? N U U Y U U N U U N\nSection C: Study Design\nIs t\nhe s\ntu dy\nt yp\ne or\nm et\nho do\nlo gy\nu ti\nlis ed\nap\npr op\nri at\ne? Y\nY Y\nY Y\nY Y\nY Y Y Is t he re f ac e va lid it y? Y Y Y Y Y Y Y Y Y Y Is t he r es ea rc h m et ho do lo gy c le ar ly s ta te d at a le ve l of d et ai l t ha t w ou ld a llo w it s re pl ic at io n? N Y Y Y Y Y N Y Y Y W as e th ic s ap pr ov al o bt ai ne d Y Y Y Y Y Y Y Y Y Y Ar e th e ou tc om es c le ar ly s ta te d an d di sc us se d in re la ti on t o th e da ta c ol le ct io n Y Y Y Y Y Y Y Y Y Y\nSection D: Results\nAr e\nal l t\nhe r\nes ul\nts c\nle ar\nly o\nut lin\ned ?\nY Y\nY Y\nY Y\nY Y\nY Y\nAr e\nco nf\nou nd\nin g\nva ri\nab le\ns ac\nco un\nte d\nfo r?\nN Y\nY Y\nY Y\nY N\nY N\nD o\nth e\nco nc\nlu si\non s\nac cu\nra te\nly r\nefl ec\nt th\ne an\nal ys\nis ?\nY Y\nY N\nY Y\nN Y\nY Y\nIs s\nub se\nt an\nal ys\nis a\nm in\nor ,\nra th\ner t\nha n\na m\naj or\n, fo\ncu s\nof t\nhe a\nrt ic\nle ?\nY Y\nY U\nY Y\nY Y\nY Y\nAr e\nsu gg\nes ti\non s\npr ov\nid ed\nf or\nf ur\nth er\na re\nas t o re se ar ch ?\nN Y\nY Y\nY Y\nN N\nY Y\nIs t\nhe re\ne xt\ner na\nl v al\nid it\ny? Y\nY Y\nY Y\nY Y\nY Y\nY\nC al\ncu la\nti on\nf or\ns ec\nti on\nv al\nid it\ny: (\nY+ N\n+U =\nT )\nIf Y\n/T <\n75 %\nor if\nN +U\n/T >\n2 5%\nt he\nn yo\nu ca\nn sa\nfe ly\nc on\ncl ud\ne th\nat t\nhe s\nec ti\non id\nen ti\nfie s\nsi gn\nifi ca\nnt o\nm is\nsi on\ns, a\nnd t\nha t\nth e\nst ud\ny\u2019 s\nva lid\nit y\nis q\nue st\nio na\nbl e.\nIt is\nim po\nrt an\nt to\nlo ok\nat\nt he\no ve\nra ll\nva lid\nit y\nas w\nel l a\ns se\nct io\nn va\nlid it\ny.\nC al\ncu la\nti on\nf or\no ve\nra ll\nva lid\nit y:\n( Y+\nN +U\n= T ) If Y /T \u2265 75 % or if N +U /T \u2264 2 5% t he n yo u ca n\nsa fe\nly c\non cl\nud e\nth at\nt he\ns tu\ndy\nis v\nal id\n.\nSe ct\nio n\nA v\nal id\nit y\nca lc\nul at\nio n:\n1 /4\n= 2\n5% n\not v\nal id\nSe ct\nio n\nB va\nlid it\ny ca\nlc ul\nat io\nn: 5\n/7 =\n7 1%\nn ot\nv al id Se ct io n C va lid it y ca lc ul at io n: 1 /5 = 2 0% n ot v al id Se ct io n D v al id it y ca lc ul at io n: 4 /6 = 6 7% n ot v al id\nO ve\nra ll\nva lid\nit y\nca lc\nul at\nio n:\n11\n/2 2\n= 50\n% n\not v\nal id\nY: Y\nes ;\nN :\nN o;\nU :\nun cl\nea r;\nN /A\n: N\not A\npp lic\nab le"
        }
    ],
    "title": "Benefit of educational intervention on Autoinjector Technique for caregivers and paediatric patients with food allergies: A literature review",
    "year": 2022
}